EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments

Pooja Khairnar, Vivek Phatale, Shalini Shukla, Akeemat O Tijani, Aachal Hedaoo, Jordan Strauss, Gabrielle Verana, Ganesh Vambhurkar, Ashana Puri iD, Saurabh Srivastava iD

Molecular Pharmaceutics · 06.05.2024 · 21 (5) · 2118-2147

DOI: 10.1021/acs.molpharmaceut.4c00144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.04.2024. Verfasst von Pooja Khairnar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Res…. Hauptthemen laut MEDLINE: Needles, Administration, Cutaneous, Drug Delivery Systems, Skin Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 243 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The various kinds of nanocarriers (NCs) have been explored for the delivery of therapeutics designed for the management of skin manifestations. The NCs are considered as one of the promising approaches for the skin delivery of therapeutics attributable to sustained release and enhanced skin penetration. Despite the extensive applications of the NCs, the challenges in their delivery via skin barrier (majorly stratum corneum) have persisted. To overcome all the challenges associated with the delivery of NCs, the microneedle (MN) technology has emerged as a beacon of hope. Programmable drug release, being painless, and its minimally invasive nature make it an intriguing strategy to circumvent the multiple challenges associated with the various drug delivery systems. The integration of positive traits of NCs and MNs boosts therapeutic effectiveness by evading stratum corneum, facilitating the delivery of NCs through the skin and enhancing their targeted delivery. This review discusses the barrier function of skin, the importance of MNs, the types of MNs, and the superiority of NC-loaded MNs. We highlighted the applications of NC-integrated MNs for the management of various skin ailments, combinational drug delivery, active targeting, in vivo imaging, and as theranostics. The clinical trials, patent portfolio, and marketed products of drug/NC-integrated MNs are covered. Finally, regulatory hurdles toward benchtop-to-bedside translation, along with promising prospects needed to scale up NC-integrated MN technology, have been deliberated. The current review is anticipated to deliver thoughtful visions to researchers, clinicians, and formulation scientists for the successful development of the MN-technology-based product by carefully optimizing all the formulation variables.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeedlesAdministration, CutaneousDrug Delivery SystemsSkin DiseasesSkinHumansNanoparticlesDrug CarriersAnimalsSkin AbsorptionMicroinjections

Stichwörter der Autor:innen

microneedlesnanocarriersskin ailmentssynergistic effecttheranosticstransdermal delivery

Substanzen

Drug Carriers

Autor:innen und Institutionen

  • Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India.
  • Department of Pharmaceutical Sciences, Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, Tennessee 37614, United States.

ORCID-Profile: Ashana Puri, Saurabh Srivastava

Zitieren

APA

Khairnar, P., Phatale, V., Shukla, S., Tijani, A. O., Hedaoo, A., Strauss, J., Verana, G., Vambhurkar, G., Puri, A., & Srivastava, S. (2024). Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments. Molecular Pharmaceutics, 21(5), 2118-2147. https://doi.org/10.1021/acs.molpharmaceut.4c00144

Vancouver

Khairnar P, Phatale V, Shukla S, Tijani AO, Hedaoo A, Strauss J, et al. Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments. Molecular Pharmaceutics. 2024;21(5):2118-2147. doi:10.1021/acs.molpharmaceut.4c00144

BibTeX
@article{Khairnar2024,
  author = {Khairnar, Pooja and Phatale, Vivek and Shukla, Shalini and Tijani, Akeemat O and Hedaoo, Aachal and Strauss, Jordan and Verana, Gabrielle and Vambhurkar, Ganesh and Puri, Ashana and Srivastava, Saurabh},
  title = {Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {5},
  pages = {2118--2147},
  doi = {10.1021/acs.molpharmaceut.4c00144}
}
Kostenlos starten →